Syros earnings
WebApr 12, 2024 · Syros Pharmaceuticals (NASDAQ:SYRS) has a market capitalization of $51.77 million and generates $14.88 million in revenue each year. The company earns $ … WebSep 23, 2024 · Earnings Estimate Revisions for Syros Pharmaceuticals, Inc. For the fiscal year ending December 2024, this company is expected to earn -$9.51 per share, which is a change of 33% from the...
Syros earnings
Did you know?
WebApr 9, 2024 · Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. About the company Rewards Revenue is forecast to grow 58.79% per year Risk Analysis Shareholders have been substantially diluted in the past year WebMar 8, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) – Equities research analysts at Oppenheimer issued their Q1 2024 earnings estimates for Syros Pharmaceuticals in a research report issued to clients and investors on Thursday, March 2nd.Oppenheimer analyst M. Breidenbach expects that the company will earn ($0.99) per …
WebAug 9, 2024 · Syros Pharmaceuticals, Inc. is estimated to report earnings on 11/04/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor,... WebMar 2, 2024 · For the full year ended December 31, 2024, Syros reported a net loss of $94.7 million or $7.49 per share compared to a net loss of $86.6 million or $13.84 per share for the same period in 2024.
WebYou can buy and sell Syros (SYRS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... SYRS Earnings-$5.40-$3.60-$1.80. $0.00. Q3 FY21. Q4 FY21. Q1 FY22. Q2 FY22. WebSyros Pharmaceuticals (SYRS) Earnings Date & Reports 641 Followers Portfolio Earnings Data Report Date May 10, 2024 Not Confirmed Period Ending 2024 (Q1) Consensus EPS Forecast -$1.05 Last Year’s EPS -$4 Same Quarter Last Year Analyst Consensus Strong Buy Based on 5 Analysts Ratings Syros Pharmaceuticals (SYRS) Earnings, Revenues Date & …
WebEarnings Summary. For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.28 per share, missing the Zacks Consensus Estimate of -$1.27 per share.
WebRepresents the company's profit divided by the outstanding shares of its common stock. -0.17. 95.53%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a … pokemon type swap rom hackWebSyros Pharmaceuticals (SYRS) Option Put/Call Volume, Put/Call Open Interest, and Put/Call Ratios to spot long and short option trends. ... Earnings Per Share (trailing 12 months), Net Income, Beta, Annual Dividend, and Dividend Yield. Note: For all markets except U.S. equities, fundamental data is not licensed for downloading. Your .csv file ... pokemon type psychic weaknessesWebFeb 28, 2024 · Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) is scheduled to be announcing its earnings results before the market opens on Thursday, March 2nd. Analysts expect the company to announce ... pokemon type strong against fightingWebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 38.36% and 21.65%, respectively, for the quarter ended September 2024. Do the … pokemon type tier list wolfeyWebApr 12, 2024 · Myelodysplastic Syndrome Epidemiology Insights. The total incident population of MDS in the 7MM was 41,850 in 2024, growing at a CAGR of 0.6% during the study period (2024–2032). pokemon type swap fan gameWebSyros Pharmaceuticals’s CEO is Nancy Simonian, appointed in Jul 2012, they has a tenure of 10.8yrs. Their total yearly compensation is US$3.1m, comprised of 19.8% salary and 80.2% bonuses, including company stock and options. They directly owns 0.4% of the company’s shares, worth US$218.3k. The average tenure of the management team and the ... pokemon type swap gameWebSyros Pharmaceuticals's Earnings Outlook Mar. 1, 2024 at 1:01 p.m. ET on Benzinga.com Top 5 4th Quarter Trades of ADAGE CAPITAL PARTNERS GP, L.L.C. Feb. 17, 2024 at 10:00 p.m. ET on... pokemon type symbols on cards